Guide to Anticoagulant Therapy: Heparin

This publication has 215 references indexed in Scilit:

• Transthoracic Cardioversion of Atrial Fibrillation and Flutter: Standard Techniques and New Advances
  The American Journal of Cardiology, 1996
• Reduction of reinfarction and angina with use of low-molecular-weight heparin therapy after streptokinase (and heparin) in acute myocardial infarction
  The American Journal of Cardiology, 1996
• Overview of randomized trials of intravenous heparin in patients with acute myocardial infarction treated with thrombolytic therapy
  The American Journal of Cardiology, 1996
• Effect of heparin on coronary arterial patency after thrombolysis with tissue plasminogen activator in acute myocardial infarction
  The American Journal of Cardiology, 1990
• The Antithrombotic Activity and Pharmacokinetics of Enoxaparine, A Low Molecular Weight Heparin, In Humans Given Single Subcutaneous Doses of 20 to 80 mg
  The Journal of Clinical Pharmacology, 1988
• Role of heparin after intravenous thrombolytic therapy for acute myocardial infarction
  The American Journal of Cardiology, 1987
• Structure-activity relationship in heparin: A synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activity
  Biochemical and Biophysical Research Communications, 1983
• The effects of phospholipid and factor Va on the inhibition of Factor Xa by antithrombin III
  Biochemical and Biophysical Research Communications, 1979
• Heparin therapy: A randomized prospective study
  American Heart Journal, 1979
• The separation of active and inactive forms of heparin
  Biochemical and Biophysical Research Communications, 1976